ADVERTISEMENT

404

Not Found

Is this what you were looking for?

tag nerves plant biology

obituary, obituaries, roundup, end of the year, COVID-19, SARS-CoV-2, pandemic, coronavirus, immunology, genetics & genomics, cell & molecular biology, HIV
Those We Lost in 2020
Amanda Heidt | Dec 18, 2020 | 7 min read
The scientific community bid farewell to researchers who furthered the fields of molecular biology, virology, sleep science, and immunology, among others.
Monoclonal Antibodies Find Utility In Cell Biology
Ricki Lewis | Dec 11, 1994 | 10+ min read
But, just as antibodies are finding increasing utility in cell biology, a new Food and Drug Administration classification for those products with clinical utility may affect researchers' access to the important technology (see accompanying story). Monoclonal History MAbs were born in 1975, when Georges Kohler and Cesar Milstein at the Medical Research Council Laboratories in Cambridge, England, fused two types of cells to form a hy
Monoclonal Antibodies Find Utility In Cell Biology
Ricki Lewis | Dec 11, 1994 | 10+ min read
But, just as antibodies are finding increasing utility in cell biology, a new Food and Drug Administration classification for those products with clinical utility may affect researchers' access to the important technology (see accompanying story). Monoclonal History MAbs were born in 1975, when Georges Kohler and Cesar Milstein at the Medical Research Council Laboratories in Cambridge, England, fused two types of cells to form a hy
The Scientist Staff | Mar 28, 2024
Drug Makers on the Apoptotic Trail
Ted Agres | Jun 24, 2001 | 4 min read
Apoptosis, a key process in the development of embryonic tissue differentiation, later helps to regulate the normal cellular life cycle by destroying damaged cells. When something goes awry, too little apoptosis can make cancer cells resistant to chemotherapy and even death-defiant. At the other extreme, premature or excessive apoptosis has been linked to neurodegenerative diseases, such as Alzheimer's, and to nerve cell loss in strokes. Not surprisingly, many major pharmaceutical companies rec
Guiding light
Amber Dance | Dec 1, 2009 | 7 min read
ul li { font-family:"Trebuchet MS",arial,helvetica; font-size:10.5pt; line-height:14pt; } By Amber Dance Guiding light How to manipulate cellular events with the right light sensing molecule and a flash of light. Using light-producing molecules to observe cellular events is standard fare in many a lab, but it’s only recently that scientists have begun to harness the power of light to manipulate biological systems experimen
Eat Yourself to Live: Autophagy’s Role in Health and Disease
Vikramjit Lahiri and Daniel J. Klionsky | Mar 1, 2018 | 10+ min read
New details of the molecular process by which our cells consume themselves point to therapeutic potential.
Notebook
The Scientist Staff | Apr 26, 1998 | 8 min read
WHAT FOLLOWS TAMOXIFEN? Warnings accompanied recent announcements from the University of Pittsburgh-based National Surgical Adjuvant Breast and Bowel Project and the National Cancer Institute in Bethesda, Md., that tamoxifen achieved a 45 percent reduction in the incidence of breast cancer compared to women who took a placebo in the Breast Cancer Prevention Trial. The 25-year-old drug still carries the risk of serious side effects for women over 50, officials said. But the overall results were
Olfaction Scientists: Sniffing Out Some New Applications
Robin Eisner | Nov 11, 1990 | 9 min read
A wide range of scientific challenges spawns a surge in basic research for this once unacclaimed discipline Most researchers long believed that the sense of smell was genetically determined and, therefore, unchangeable. But at least one scientist--Charles Wysocki of the Monell Chemical Senses Center in Philadelphia--doubted this theory. Wysocki, a psychobiologist who investigates the genetics of olfaction in the 45 percent of the adult population who can't detect androstenone, a component in s

Run a Search

ADVERTISEMENT